427 related articles for article (PubMed ID: 26339430)
1. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
Jiwani S; Bornhost J; Alapat D
Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
[TBL] [Abstract][Full Text] [Related]
2. An approach for plasma cell myeloma diagnosis by two-color flow cytometry based on kappa/lambda ratios of CD38-gated plasma cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
Int J Immunopathol Pharmacol; 2013; 26(2):479-83. PubMed ID: 23755763
[TBL] [Abstract][Full Text] [Related]
3. An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
Diagn Pathol; 2012 Sep; 7():131. PubMed ID: 23021410
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
Singh G
Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
[TBL] [Abstract][Full Text] [Related]
5. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
Levinson SS
Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
[TBL] [Abstract][Full Text] [Related]
7. Dual Expression of Immunoglobulin Light Chains in Plasma Cell Myeloma: A Case Report and Literature Review.
Suresh J; Wu Y; Sabaratnam R; Brijlall S; Kyle B; Torlakovic EE
Appl Immunohistochem Mol Morphol; 2023 Aug; 31(7):447-451. PubMed ID: 36314594
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
[TBL] [Abstract][Full Text] [Related]
9. Biphenotypic plasma cell myeloma.
Kurt H; Ferreira KA
Blood; 2019 Apr; 133(14):1611. PubMed ID: 30948370
[No Abstract] [Full Text] [Related]
10. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
[TBL] [Abstract][Full Text] [Related]
11. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD138-positive plasma cells.
Nakayama-Ichiyama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
Leuk Lymphoma; 2012 Nov; 53(11):2205-9. PubMed ID: 22506669
[TBL] [Abstract][Full Text] [Related]
13. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains.
Gu HJ; Cho SY; Lee J; Sung JY; Park TS
Clin Chem Lab Med; 2017 Jan; 55(1):e21-e24. PubMed ID: 27442368
[No Abstract] [Full Text] [Related]
14. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
15. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
Nelson M; Brown RD; Gibson J; Joshua DE
Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
[TBL] [Abstract][Full Text] [Related]
16. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
[TBL] [Abstract][Full Text] [Related]
17. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
Wearne A; Joshua DE; Kronenberg H
Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
[TBL] [Abstract][Full Text] [Related]
18. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
19. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
[TBL] [Abstract][Full Text] [Related]
20. [Light chain myeloma or the pitfalls of myeloma diagnosis].
Zufferey P; Pugin P; Regamey C
Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
